Trump's Ozempic Remark Hits Pharma Stocks
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Former President Donald Trump pledges to slash prices of weight-loss drugs Ozempic and Wegovy, sending pharmaceutical stocks tumbling and sparking healthcare debate.
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
Plant-based pioneer Beyond Meat faces investor exodus as shares hit record lows amid cooling consumer demand and production challenges in the competitive meat-free market.
Native American communities face critical shortages of diabetes medications like Ozempic as wealthy New Yorkers exploit prescriptions for weight loss, creating a healthcare crisis for vulnerable populations.
The London Stock Exchange is experiencing a remarkable revival with three major IPOs launching simultaneously, signalling renewed confidence in UK markets under Chancellor Rachel Reeves' economic strategy.
London's FTSE 100 experienced significant losses after shock GDP data revealed the UK economy contracted in October, with retail and mining stocks leading the decline.
Exclusive analysis reveals growing concerns for London's financial hub status as another FTSE 100 firm considers moving its primary listing overseas, sparking fears of an exodus from the City.
London's blue-chip index suffers significant losses amid shock GDP contraction and global market turbulence. Expert analysis on the economic outlook.
Elon Musk's net worth plunges dramatically as Tesla shares nosedive following disappointing earnings and production concerns, wiping out billions in market value.
London's FTSE 100 index faces significant losses amid economic stagnation fears and global market uncertainty. Expert analysis reveals what's next for UK investors.
Beyond Meat faces catastrophic stock plunge as consumer appetite for plant-based products wanes. Analysis reveals troubling trends for the once high-flying fake meat sector.
Pfizer announces a surprising turnaround in its weight-loss strategy, advancing two new daily pills in a heated battle for the lucrative obesity drug market dominated by injectables.
The London Stock Exchange faces a sharp sell-off as new data reveals zero economic growth in April, fuelling concerns over persistent inflation and delaying hopes for a Bank of England interest rate cut.
Exclusive analysis reveals how Oracle's mysterious stock movements and a potential TikTok ownership stake could signal a major shift in global tech and create opportunities for savvy investors.
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.
Tesla shares plummet as Elon Musk's aggressive pivot to AI and robotics sparks a massive investor sell-off, wiping billions from the company's valuation and raising serious questions about its future direction.
Shares in Donald Trump's Truth Social parent company, DJT, have nosedived, erasing billions from its market value and raising serious questions about its long-term viability.
Discover how to transform common vegetable peelings into a rich, flavourful homemade stock. This zero-waste chef's secret saves money and reduces food waste instantly.
THG faces a severe stock market crash after reporting disappointing Q3 revenue, with its key MyProtein brand struggling in European markets. The company slashes its full-year profit forecast, sparking investor panic.
The London Stock Exchange faced a sharp sell-off on Thursday, with the FTSE 100 dragged down by a global tech rout and disappointing corporate earnings. Key figures like Elon Musk face scrutiny.
Danish pharmaceutical giant Novo Nordisk announces major £90 million expansion at its Gatwick facility to meet soaring global demand for its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, creating new high-skilled jobs.
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
Global markets reel as former President Donald Trump announces sweeping new tariffs on the EU, targeting key industries from cars to pharmaceuticals. The move sends the pound and euro tumbling and casts a shadow over Novo Nordisk's major UK investment pla
Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
Iconic department store Macy's executes a remarkable retail revival, with shares skyrocketing after addressing customer frustrations head-on. Discover the strategy behind their impressive comeback.
London's FTSE 100 index suffers significant losses as Rolls-Royce shares plummet 9% and Burberry issues profit warning, triggering widespread market anxiety.
The FTSE 100 and S&P 500 surge to unprecedented levels, fuelled by a monumental earnings report from AI chipmaker Nvidia. Discover how the tech giant's performance is reshaping global markets.
London's FTSE 100 experienced a dramatic session with Rolls-Royce and Ocado leading gains, while mining stocks faced sharp declines. Get the full market analysis and closing figures.